Company: VRCA
Filing Date: 2025-04-11
Form Type: PRE 14A
Source: 0001193125-25-079118
Chunk: 20

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-11
Form: PRE 14A
Chunk 20
---
 executive and director compensation, including the authority to approve the consultant’s reasonable fees and other retention terms. Under the charter, the Compensation Committee may select, or receive advice from, a compensation consultant, independent legal counsel or other adviser to the Compensation Committee, other than in-houselegal counsel and certain other types of advisers, only after taking into consideration 13

six factors, prescribed by the SEC and Nasdaq, that bear upon the adviser’s independence. The Compensation Committee has engaged Alpine Rewards LLC (“Alpine”) as its compensation consultant since 2023. Our Compensation Committee identified Alpine based on Alpine’s general reputation in the industry. During 2024, the Compensation Committee requested that Alpine:

| • |     | assist in providing competitive compensation data for all of the Company’s executive positions and its Board of Directors; |

| • |     | propose go-forward changes relating to executive cash and equity compensation; and |

| • |     | review our non-employee director compensation policy and recommend changes as deemed appropriate to maintain or improve competitiveness. |

The Compensation Committee has analyzed whether the work of Alpine as compensation consultant raises any conflict of interest, taking into account relevant factors in accordance with SEC rules and Nasdaq listing standards. Based on its analysis, our Compensation Committee determined that the work of Alpine and the individual compensation advisors employed by Alpine does not create any conflict of interest pursuant to the SEC rules and Nasdaq listing standards. Nominating and Corporate Governance Committee The Nominating and Corporate Governance Committee is composed of two directors: Mr. Prygocki and Dr. Eichenfield. Dr. Eichenfield serves as the Chair of the Nominating and Corporate Governance Committee. All members of the Nominating and Corporate Governance Committee are independent (as independence is currently defined in Rule 5605(a)(2) of the Nasdaq listing standards). The Nominating and Corporate Governance Committee met one time during 2024. The Board has adopted a written Nominating and Corporate Governance Committee charter that is available to stockholders on the Company’s website at www.verrica.com. The Nominating and Corporate Governance Committee’s responsibilities include:

| • |     | identifying, reviewing, evaluating and recommending candidates to serve on our Board of Directors; |

| • |     | determining the minimum qualifications for service on our board of director; |

| • |     | evaluating director performance on the board and applicable committees of the board and determining whether continued service on our board is appropriate; |

| • |     | evaluating nominations by stockholders of candidates